Latest analyst ratings

? ARWR: Arrowhead Pharmaceuticals received a positive evaluation, being rated as a "buy" by Mayank Mamtani, a 0.06-star analyst at B.Riley Financial. He set a price target of $60.00, indicating a significant upside of 145.48%.

? ON: ON Semiconductor also earned a "buy" rating from Ross Seymore, a highly regarded 4.99-star analyst at Deutsche Bank. The price target he established is $90.00, suggesting a solid 42.27% upside.

? PJT: PJT Partners was rated as a "buy" by Devin Ryan, a 4.88-star analyst at JMP Securities, who set a price target of $94.00, forecasting an appealing 21.47% upside.

? SIRI: Sirius XM Holdings received a "hold" rating from Jeffrey Wlodarczak, a 3.68-star analyst at Pivotal Research. His price target is $4.80, signifying a modest 12.2% upside.

? TEF: Telefonica was also rated as a "hold," this time by Carl Murdock Smith, a 3.1-star analyst at Berenberg Bank. He set a price target of $3.30, indicating a slight downside of -2.37%.

? FURC: Faurecia garnered a positive assessment from Romain Gourvil, a 1.04-star analyst at Berenberg Bank, who gave it a "buy" rating. His price target is $26.00, predicting a notable 68.08% upside.

? GPK: Graphic Packaging received a "buy" rating from George Staphos, a 4.52-star analyst at Bank of America Securities. He set a price target of $29.00, suggesting a solid 37.37% upside.

? PRFT: Perficient was given a "buy" rating by Mayank Tandon, a 3.27-star analyst at Needham, who established a price target of $73.00, indicating a 44.02% upside. Additionally, it received a "hold" rating from Brian Kinstlinger, a 0.2-star analyst at Alliance Global Partners, who set the same price target.

? NOMD: Nomad Foods received a "buy" rating from Robert Dickerson, a 2.84-star analyst at Jefferies. His price target is $23.00, predicting a substantial 61.64% upside.

? ARGX: Argenx Se was rated as a "buy" by Jason Butler, a 0.07-star analyst at JMP Securities. He set a price target of $548.00, forecasting a 27.71% upside.

? MBUU: Malibu Boats received a "hold" rating from Eric Wold, a 1.52-star analyst at B.Riley Financial. His price target is $56.00, indicating a 30.76% upside.

? TSE:HTL: Hamilton Thorne received a "buy" rating from Justin Keywood, a 1.16-star analyst at Stifel Nicolaus. He set a price target of $3.00, predicting a significant 85.82% upside.

? SILV: SilverCrest Metals was rated as a "hold" by Stephen Soock, a 0.15-star analyst at Stifel Nicolaus. His price target is $7.75, indicating a 31.54% upside.

? TSE:SIL: SilverCrest Metals, listed on the Toronto Stock Exchange, received the same "hold" rating and price target from Stephen Soock, a 0.15-star analyst.

? SISXF: Savaria received a "buy" rating from Justin Keywood, a 1.16-star analyst at Stifel Nicolaus. His price target is $25.00, suggesting a substantial 64.25% upside.

? TSE:SIS: Savaria, also listed on the Toronto Stock Exchange, received the same "buy" rating and price target from Justin Keywood, a 1.16-star analyst.

? TSE:TPZ: Topaz Energy Corp was rated as a "buy" by Michael Dunn, a 2.54-star analyst at Stifel Nicolaus. He set a price target of $25.50, indicating a 26.98% upside.

? OR: Osisko Gold Royalties received a "buy" rating from Ingrid Rico, a 1.82-star analyst at Stifel Nicolaus. Her price target is $27.00, predicting a solid 44.59% upside.

? TSE:OR: Osisko Gold Royalties, also listed on the Toronto Stock Exchange, received the same "buy" rating and price target from Ingrid Rico, a 1.82-star analyst.

? GBNXF: Gibson Energy received a "buy" rating from Cole Pereira, a 4.73-star analyst at Stifel Nicolaus. His price target is $27.00, indicating an appealing 17.77% upside.

? TSE:GEI: Gibson Energy, also listed on the Toronto Stock Exchange, received the same "buy" rating and price target from Cole Pereira, a 4.73-star analyst.

? ERO: Ero Copper was rated as a "hold" by Alex Terentiew, a 0.35-star analyst at Stifel Nicolaus. His price target is $30.00, suggesting a 51.4% upside.

? TSE:ERO: Ero Copper, listed on the Toronto Stock Exchange, received the same "hold" rating and price target from Alex Terentiew, a 0.35-star analyst.

? CTLT: Catalent received a "hold" rating from Eric Coldwell, a 4.25-star analyst at Robert W. Baird. His price target is $45.00, indicating a 30.26% upside.

? TSE:ASCU: Arizona Sonoran Copper Co., Inc. received a "buy" rating from Alex Terentiew, a 0.35-star analyst at Stifel Nicolaus. He set a price target of $3.70, indicating a significant upside of 121.19%.

? USAS: Americas Gold and Silver was assigned a "hold" rating by Stephen Soock, a 0.15-star analyst at Stifel Nicolaus. His price target is $0.60, suggesting a substantial upside of 164.52%.

? TSE:USA: Americas Gold and Silver, also listed on the Toronto Stock Exchange, received the same "hold" rating and price target from Stephen Soock, a 0.15-star analyst.

? FQVLF: First Quantum Minerals received a "hold" rating from Alex Terentiew, a 0.35-star analyst at Stifel Nicolaus. His price target is $24.00, predicting a moderate upside of 51.66%.

? TSE:FM: First Quantum Minerals, listed on the Toronto Stock Exchange, received the same "hold" rating and price target from Alex Terentiew, a 0.35-star analyst.

? AAPL: Apple was rated as a "hold" by David Vogt, a highly regarded 4.57-star analyst at UBS. He set a price target of $190.00, forecasting a modest 19.41% upside.

? CAT: Caterpillar received a "buy" rating from Tami Zakaria, a 4.73-star analyst at J.P. Morgan. She established a price target of $320.00, indicating a solid 20.74% upside.

? PANW: Palo Alto Networks also earned a "buy" rating from Joseph Gallo, a 2.7-star analyst at Jefferies. The price target he set is $285.00, suggesting an 18.14% upside.

? HOWL: Werewolf Therapeutics received a "buy" rating from Andres Y. Maldonado, a 0.33-star analyst at H.C. Wainwright. His price target is $15.00, forecasting an impressive 349.6% upside.

? ASND: Ascendis Pharma was rated as a "buy" by Andreas Argyrides, a 0.19-star analyst at Wedbush. He set a price target of $192.00, indicating a substantial 62.76% upside.

? LIFE: aTyr Pharma also received a "buy" rating, this time from Sean Kim PhD, a 0.39-star analyst at JonesTrading. He established a price target of $12.00, forecasting an extraordinary 1,620.0% upside.

? XOMA: Xoma earned a "buy" rating from Joseph Pantginis, a 0.08-star analyst at H.C. Wainwright. He set a price target of $74.00, suggesting an impressive 314.8% upside.

? EGO: Eldorado Gold received a "buy" rating from Mike Parkin, a 0.28-star analyst at National Bank. His price target is $19.00, indicating a modest 5.33% upside.

? TSE:ELD: Eldorado Gold, listed on the Toronto Stock Exchange, received the same "buy" rating and price target from Mike Parkin, a 0.28-star analyst.

? ARM: ARM Holdings PLC ADR was rated as a "buy" by Carlos Peinador, a 1.25-star analyst at Banco Santander. He set a price target of $57.00, indicating a 29.44% upside.

? CHKP: Check Point received a "buy" rating from Joseph Gallo, a 2.7-star analyst at Jefferies. His price target is $160.00, suggesting a modest 8.92% upside.

? ELF: e.l.f. Beauty was also rated as a "buy," this time by Peter Grom, a 0.37-star analyst at UBS. He set a price target of $138.00, indicating a 37.66% upside.

? ABSSF: Airboss of America received a "buy" rating from Tim James, a highly regarded 4.54-star analyst at TD Securities. His price target is $7.00, forecasting a solid 57.22% upside.

? TSE:BOS: Airboss of America, listed on the Toronto Stock Exchange, received the same "buy" rating and price target from Tim James, a 4.54-star analyst.

? TMXXF: TMX Group was assigned a "hold" rating by Graham Ryding, a 4.72-star analyst at TD Securities. His price target is $31.00, suggesting a moderate 6.98% upside.

? TSE:X: TMX Group, also listed on the Toronto Stock Exchange, received the same "hold" rating and price target from Graham Ryding, a 4.72-star analyst.

? PWCDF: Power Corp of Canada received a "buy" rating from Graham Ryding, a 4.72-star analyst at TD Securities. His price target is $40.00, indicating a 29.44% upside.

? TSE:POW: Power Corp of Canada, listed on the Toronto Stock Exchange, received the same "buy" rating and price target from Graham Ryding, a 4.72-star analyst.

? VERV: Verve Therapeutics received a "buy" rating from Cory Jubinville, PhD, a 3.58-star analyst at LifeSci Capital. He set a price target of $55.00, forecasting an impressive 293.2% upside.

? CRTO: Criteo SA earned a "hold" rating from Brian Fitzgerald, a highly regarded 4.86-star analyst at Wells Fargo. His price target is $37.00, suggesting a moderate 45.72% upside.

? PGR: Progressive was assigned a "hold" rating by Elyse Greenspan, a highly regarded 4.9-star analyst at Wells Fargo. She set a price target of $144.00, forecasting a modest 2.2% upside.

? KTRA: Kintara Therapeutics received a "hold" rating from Jason McCarthy, a 0.06-star analyst at Maxim Group. No specific price target was provided.

? PACB: Pacific Biosciences was rated as a "buy" by Ross Osborn, a 0.14-star analyst at Cantor Fitzgerald. He set a price target of $11.00, suggesting a substantial 76.51% upside.

? LIFE: aTyr Pharma, once again, received a "buy" rating, this time from Joseph Pantginis, a 0.08-star analyst at H.C. Wainwright. His price target is $35.00, forecasting an extraordinary 1,620.0% upside.

? LAZ: Lazard earned a "buy" rating from Stephen Biggar, a highly regarded 4.59-star analyst at Argus Research. He set a price target of $36.00, indicating a solid 34.13% upside.

? PFE: Pfizer was assigned a "hold" rating by Trung Huynh, a 4.61-star analyst at UBS. His price target is $34.00, suggesting a moderate 30.64% upside.

? TMUS: T Mobile US received a "buy" rating from Ivan Feinseth, a 4.74-star analyst at Tigress Financial. He established a price target of $204.00, forecasting a solid 29.97% upside.

? HAS: Hasbro also garnered a "buy" rating from Jim Corridore, a 3.75-star analyst at Argus Research. His price target is $65.00, indicating a notable 40.36% upside.

? AN: AutoNation was rated as a "buy" by Taylor Conrad, a 0.63-star analyst at Argus Research. He set a price target of $165.00, suggesting a substantial 20.26% upside.

? WGS: GeneDx Holdings received a "buy" rating from Mark Massaro, a 0.07-star analyst at BTIG. His price target is $6.00, forecasting an impressive 274.53% upside.

? CYBN: Cybin received a "buy" rating from Patrick Trucchio, a 0.07-star analyst at H.C. Wainwright. He set a price target of $10.00, indicating an extraordinary 801.64% upside. Additionally, it is listed on the Toronto Stock Exchange under TSE:CYBN, where it received the same "buy" rating and an even more substantial upside of 5,335.91%.

? DIS: Walt Disney was rated as a "buy" by Vijay Jayant, a 1.99-star analyst at Evercore ISI. His price target is $100.00, forecasting a solid 31.51% upside.

? ANET: Arista Networks earned a "buy" rating from Amit Daryanani, a 4.84-star analyst at Evercore ISI. He set a price target of $210.00, suggesting a notable 22.43% upside.

? CHGG: Chegg received a "buy" rating from Alex Fuhrman, a 0.09-star analyst at Craig-Hallum. He established a price target of $13.00, indicating a solid 28.41% upside.

? VRNS: Varonis Systems also garnered a "buy" rating from Chad Bennett, a 1.79-star analyst at Craig-Hallum. His price target is $37.00, suggesting an 18.38% upside.

? PRTS: CarParts.com Inc was rated as a "buy" by Ryan Sigdahl, a highly regarded 4.77-star analyst at Craig-Hallum. He set a price target of $8.00, indicating a notable 97.01% upside.

? VFC: VF received a "buy" rating from Dana Telsey, a 0.34-star analyst at Telsey Advisory. She set a price target of $20.00, forecasting a 12.15% upside.

? AXNX: Axonics Modulation Technologies was rated as a "buy" by Michael Matson, a 0.58-star analyst at Needham. He established a price target of $63.00, suggesting a solid 42.42% upside.

? DENN: Denny's received a "buy" rating from Jake Bartlett, a 4.87-star analyst at Truist Financial. His price target is $12.00, indicating a notable 36.42% upside.

? CRTO: Criteo SA earned a "buy" rating from Matthew Thornton, a 4.78-star analyst at Truist Financial. He set a price target of $40.00, suggesting a moderate 45.72% upside.

? DIS: Walt Disney, once again, was rated as a "buy," this time by David Joyce, a 1.57-star analyst at Seaport Global. His price target is $96.00, forecasting a solid 31.51% upside.

? BABA: Alibaba was assigned a "buy" rating by Youssef Squali, a highly regarded 4.86-star analyst at Truist Financial. He set a price target of $126.00, indicating a substantial 68.84% upside.

? IPGP: IPG Photonics received a "buy" rating from Mark Miller, a 4.95-star analyst at Benchmark Co. He set a price target of $134.00, suggesting a solid 50.04% upside.

? FNV: Franco-Nevada was rated as a "hold" by Greg Barnes, a 4.16-star analyst at TD Securities. His price target is $145.00, forecasting a moderate 21.61% upside.

? FNV: Franco-Nevada was assessed with a "hold" rating by Greg Barnes, a top-rated 4.16-star analyst at TD Securities. He set a price target of $145.00, indicating a reasonable 21.79% upside.

? PRTS: CarParts.com Inc received a "buy" rating from Darren Aftahi, a well-regarded 4.03-star analyst at Roth MKM. He established a price target of $4.00, forecasting a significant 97.01% upside.

? COMM: CommScope Holding earned a "buy" rating from Tim Savageaux, a highly rated 4.93-star analyst at Northland Securities. His price target is $4.00, indicating a substantial 327.7% upside.

? CHGG: Chegg was assigned a "hold" rating by Michael Grondahl, a 4.6-star analyst at Northland Securities. His price target is $13.00, forecasting a solid 28.41% upside.

? HLIT: Harmonic received a "buy" rating from Tim Savageaux, a highly regarded 4.93-star analyst at Northland Securities. He set a price target of $18.00, indicating a significant 84.99% upside.

? TREE: Lendingtree garnered a "hold" rating from Michael Grondahl, a 4.6-star analyst at Northland Securities. His price target is $24.00, suggesting a substantial 116.8% upside.

? INTC: Intel was rated as a "buy" by Gus Richard, a top-tier 4.96-star analyst at Northland Securities. He set a price target of $56.00, forecasting a modest 4.93% upside.

? WK: Workiva received a "buy" rating from Michael Grondahl, a 4.6-star analyst at Northland Securities. His price target is $110.00, indicating a notable 28.83% upside.

? TRNS: Transcat earned a "buy" rating from Ted Jackson, a 0.79-star analyst at Northland Securities. He set a price target of $120.00, suggesting a solid 20.08% upside.

? ENPH: Enphase Energy was rated as a "buy" by Tom Curran, a 0.46-star analyst at Seaport Global. His price target is $147.00, forecasting a significant 46.76% upside.

? PFE: Pfizer was assigned a "hold" rating by Chris Schott, a 3.61-star analyst at J.P. Morgan. His price target is $34.00, suggesting a moderate 30.64% upside.

? PRTS: CarParts.com Inc received a "buy" rating from Ryan Meyers, a 0.25-star analyst at Lake Street. He established a price target of $7.00, indicating a substantial 97.01% upside.

? PETS: Petmed Express was rated as a "buy" by Ryan Meyers, a 0.25-star analyst at Lake Street. His price target is $13.00, forecasting a solid 25.27% upside.

? ATEC: Alphatec Holdings garnered a "buy" rating from Brooks O'Neil, a 0.76-star analyst at Lake Street. His price target is $32.00, suggesting a substantial 159.28% upside.

? GAIA: Gaia received a "buy" rating from Mark Argento, a highly regarded 4.6-star analyst at Lake Street. He set a price target of $6.00, indicating a notable 136.22% upside.

? PINS: Pinterest was assigned a "hold" rating by Scott Devitt, a 4.87-star analyst at Wedbush. His price target is $32.00, forecasting a moderate 38.53% upside.

? VRNS: Varonis Systems also garnered a "hold" rating from Daniel Ives, a 4.92-star analyst at Wedbush. His price target is $35.00, suggesting an 18.38% upside.

? ON: ON Semiconductor received a "buy" rating from Craig Ellis, a highly regarded 4.96-star analyst at B.Riley Financial. He set a price target of $110.00, forecasting a solid 42.27% upside.

? CWH: Camping World Holdings earned a "buy" rating from Brandon Rolle, a 0.84-star analyst at D.A. Davidson. His price target is $23.00, indicating a substantial 65.19% upside.

? ASCU: Arizona Sonoran Copper Co., Inc. was rated as a "buy" by Eric Winmill, a 1.22-star analyst at Scotiabank. His price target is $3.25, suggesting a notable 121.19% upside.

? FSM: Fortuna Silver Mines received a "hold" rating from Eric Winmill, a 1.22-star analyst at Scotiabank. His price target is $4.25, forecasting a moderate 42.71% upside. Additionally, it is listed on the Toronto Stock Exchange under TSE:FVI, where it received the same "hold" rating and an even more modest upside of 43.25%.

? HTBK: Heritage Commerce was rated as a "buy" by Gary Tenner, a top-rated 4.54-star analyst at D.A. Davidson. He set a price target of $10.00, indicating a reasonable 21.9% upside.

? WW: WW International received a "buy" rating from Linda Bolton Weiser, a 3.78-star analyst at D.A. Davidson. Her price target is $12.50, forecasting a significant 71.85% upside.

? PACW: Pacwest Bancorp was assigned a "buy" rating by Gary Tenner, a top-tier 4.54-star analyst at D.A. Davidson. He set a price target of $14.00, suggesting a notable 37.61% upside.

Previous update:

? TOST: Jeff Cantwell, a 4.63 star analyst from Wells Fargo, gave Toast Inc a sell rating and a price target of $16.00, which implies a 61.7% downside from the current price.

? VRDN: Viridian Therapeutics received two buy ratings from Laura Chico of Wedbush and Rami Katkhuda of LifeSci Capital, both with low star rankings. They set price targets of $37.00 and $57.00 respectively, which suggest a huge upside potential of over 240%.

? SHOP: Shopify was rated as a buy by Jeff Cantwell, a 4.63 star analyst from Wells Fargo. He set a price target of $65.00, which indicates a 44.85% upside from the current price.

? TTWO: Take-Two got a buy rating from Matthew Thornton, a 4.78 star analyst from Truist Financial. He set a price target of $155.00, which implies a 20.26% upside from the current price.

? THTX: Theratechnologies was rated as a buy by Justin Walsh, a 0.08 star analyst from JonesTrading. He set a price target of $5.00, which suggests a massive upside of 477.55%.

? DRCT: Direct Digital Holdings received a buy rating from Darren Aftahi, a 4.03 star analyst from Roth MKM. He set a price target of $4.75, which indicates a 186.56% upside from the current price.

? FQVLF: First Quantum Minerals got a hold rating from Ralph M. Profiti, a 3.28 star analyst from Eight Capital. He set a price target of $24.24, which implies a 20% upside from the current price.

? DAWN: Day One Biopharmaceuticals received a hold rating from Matthew Biegler, a 0.15 star analyst from Oppenheimer. He set a price target of $38.33, which suggests a huge upside potential of 276.89%.

? NWG: NatWest Group got three ratings: one buy and two holds. The buy rating came from Peter Richardson, a 3.09 star analyst from Berenberg Bank, who set a price target of $300.00, which implies a 14.03% downside from the current price. The hold ratings came from Raul Sinha, a 4.44 star analyst from J.P. Morgan, and Benjamin Toms, a 4.74 star analyst from RBC Capital, who both set the same price target of $290.00, which also indicates a 14.03% downside.

? RSG: Republic Services received a hold rating from James Schumm, a 3.33 star analyst from TD Cowen. He set a price target of $160.00, which implies a 14.92% upside from the current price.

? OLN: Olin got a hold rating from Frank Mitsch, a 3.24 star analyst from Fermium Research. He set a price target of $48.00, which indicates a 32.26% upside from the current price.

? ON: ON Semiconductor received two ratings: one buy and one hold. The buy rating came from Christopher Rolland, a 4.98 star analyst from Susquehanna, who set a price target of $90.00, which implies a 35.36% upside from the current price. The hold rating came from Anthony Stoss, a 4.64 star analyst from Craig-Hallum, who set the same price target of $78.00.

? LYB: LyondellBasell was rated as a hold by Frank Mitsch, a 3.24 star analyst from Fermium Research. He set a price target of $96.00, which suggests a 13.61% upside from the current price

? CHKP: Check Point received two ratings: one buy and one hold. The buy rating came from Shaul Eyal, a 4.99 star analyst from TD Cowen, who set a price target of $160.00, which implies a 7.01% upside from the current price. The hold rating came from Rob Owens, a 4.97 star analyst from Piper Sandler, who set a lower price target of $125.00.

? OWL: Blue Owl Capital got a buy rating from Brian McKenna, a 4.12 star analyst from JMP Securities. He set a price target of $18.00, which indicates a 25.1% upside from the current price.

? BL: BlackLine was rated as a buy by Patrick Walravens, a 0.09 star analyst from JMP Securities. He set a price target of $81.00, which suggests a 22.24% upside from the current price.

? META: Meta Platforms received a buy rating from Andrew Boone, a 0.19 star analyst from JMP Securities. He set a price target of $380.00, which implies a 29.38% upside from the current price.

? LITE: Lumentum Holdings got a buy rating from Alex Henderson, a 4.88 star analyst from Needham. He set a price target of $50.00, which indicates a 36.82% upside from the current price.

? ON: ON Semiconductor received a hold rating from Anthony Stoss, a 4.64 star analyst from Craig-Hallum. He set a price target of $78.00, which implies a 35.36% upside from the current price.

? FTHM: Fathom Holdings was rated as a buy by Darren Aftahi, a 4.03 star analyst from Roth MKM. He set a price target of $6.00, which suggests a massive upside of 211.42%.

? FQVLF: First Quantum Minerals got three hold ratings from different analysts with similar star rankings and price targets. Chris LaFemina of Jefferies and Greg Barnes of TD Securities both set a price target of $24.24, which indicates a 20% upside from the current price. Greg Barnes also gave the same rating and price target to the TSE:FM symbol of First Quantum Minerals.

? RYAN: Ryan Specialty Group received a hold rating from Michael Zaremski, a 4.56 star analyst from BMO Capital. He set a price target of $49.00, which suggests a 13.6% upside from the current price.

? MCD: McDonald's got a buy rating from Andrew Charles, a 4.72 star analyst from TD Cowen. He set a price target of $300.00, which implies a 21.03% upside from the current price.

? VRDN: Viridian Therapeutics received two buy ratings from Jason Butler of JMP Securities and Laura Chico of Wedbush, both with low star rankings. They set price targets of $42.00 and $37.00 respectively, which suggest huge upside potentials of over 240%.

? CJREF: Corus Entertainment received a hold rating from Scott Fletcher, a 0.59 star analyst from CIBC. He set a price target of $1.15, which suggests a 146% upside from the current price. He also gave the same rating and price target to the TSE:CJR.B symbol of Corus Entertainment.

? RVPH: Reviva Pharmaceuticals Holdings got a buy rating from Scott Henry, a 2.18 star analyst from Roth MKM. He set a price target of $12.00, which indicates a huge upside potential of 255.47%.

? ON: ON Semiconductor received two hold ratings from different analysts with similar star rankings and price targets. Kinngai Chan of Summit Redstone Partners and Anthony Stoss of Craig-Hallum both set a price target of $113.05, which implies a 35.36% upside from the current price.

? NGD: New Gold got two hold ratings from Mike Parkin, a 0.28 star analyst from National Bank. He set a price target of $2.00, which suggests a 17.5% upside from the current price. He also gave the same rating and price target to the TSE:NGD symbol of New Gold.

? OCANF: OceanaGold received a buy rating from Mike Parkin, a 0.28 star analyst from National Bank. He set a price target of $4.00, which indicates a 52.25% upside from the current price. He also gave the same rating and price target to the TSE:OGC symbol of OceanaGold.

? TSE:TF: Timbercreek Financial got a hold rating from Jaeme Gloyn, a 4.54 star analyst from National Bank. He set a price target of $7.00, which suggests a 39.51% upside from the current price.

? APYRF: Allied Properties Real Estate Investment Trust received a buy rating from Brad Sturges, a 0.4 star analyst from Raymond James. He set a price target of $20.00, which implies a 39.3% upside from the current price. He also gave the same rating and price target to the TSE:AP.UN symbol of Allied Properties Real Estate Investment Trust.

? FQVLF: First Quantum Minerals received four hold ratings from different analysts with similar star rankings and price targets. Liam Fitzpatrick of Deutsche Bank, Chris LaFemina of Jefferies, Greg Barnes of TD Securities and Ralph M. Profiti of Eight Capital all set a price target of $36.00, which indicates a 20% upside from the current price. Liam Fitzpatrick and Greg Barnes also gave the same rating and price target to the TSE:FM symbol of First Quantum Minerals.

? TSE:FN: First National Financial received a hold rating from Jaeme Gloyn, a 4.54 star analyst from National Bank. He set a price target of $38.00, which implies a 18.74% upside from the current price.

? PWCDF: Power Corp of Canada got a hold rating from Phil Hardie, a 4.92 star analyst from Scotiabank. He set a price target of $42.40, which suggests a 34.17% upside from the current price. He also gave the same rating and price target to the TSE:POW symbol of Power Corp of Canada.

Sure, I can paraphrase the data for you. Here are some possible sentences for each symbol:

? IFNNF: Infineon Technologies AG got a buy rating from Juergen Wagner, a 0.95 star analyst from Stifel Nicolaus. He set a price target of $46.00, which suggests a 51.43% upside from the current price.

? MONRF: Moncler S.p.A. received a hold rating from Rogerio Fujimori, a 4.06 star analyst from Stifel Nicolaus. He set a price target of $56.00, which implies a 30.2% upside from the current price.

? SAVA: Cassava Sciences was rated as a buy by Soumit Roy, a 0.14 star analyst from JonesTrading. He set a price target of $75.00, which indicates a huge upside potential of 400.25%.

? HMDPF: Hammond Power Solutions got a buy rating from Matthew Lee, a 4.03 star analyst from Canaccord Genuity. He set a price target of $85.00, which suggests a 34.98% upside from the current price. He also gave the same rating and price target to the TSE:HPS.A symbol of Hammond Power Solutions.

? EQGPF: Equitable Group received a buy rating from Jaeme Gloyn, a 4.54 star analyst from National Bank. He set a price target of $90.00, which implies a 44.28% upside from the current price. He also gave the same rating and price target to the TSE:EQB symbol of Equitable Group.

? EHMEF: goeasy got a hold rating from Phil Hardie, a 4.92 star analyst from Scotiabank. He set a price target of $145.00, which indicates a 43.13% upside from the current price. He also gave the same rating and price target to the TSE:GSY symbol of goeasy.

? IFCZF: Intact Financial Corporation received a buy rating from Phil Hardie, a 4.92 star analyst from Scotiabank. He set a price target of $227.00, which suggests a 17.24% upside from the current price. He also gave the same rating and price target to the TSE:IFC symbol of Intact Financial Corporation.

? IDRSF: Idorsia Ltd received a sell rating from Emmanuel Papadakis, a 4.4 star analyst from Deutsche Bank. He set a very low price target of $1.00, which suggests a massive upside of 1,988.31%.

? TSE:ARE: Aecon Group Inc. got a hold rating from Sabahat Khan, a 3.63 star analyst from RBC Capital. He set a price target of $10.00, which implies a 35.05% upside from the current price.

? SSLLF: Siltronic was rated as a hold by Robert Sanders MBA, a 4.7 star analyst from Deutsche Bank. He set a price target of $70.00, which indicates a 10.83% upside from the current price.

? GGDVF: Guangdong Investment received a hold rating from Evan Li, a 2.22 star analyst from HSBC. He set a price target of $6.30, which suggests a 12.5% upside from the current price.

? SCBFF: Standard Chartered got a buy rating from Jason Napier, a 4.63 star analyst from UBS. He set a price target of $8.75, which implies a 58.09% upside from the current price.

? PUKPF: Prudential was rated as a buy by Nasib Ahmed, a 0.9 star analyst from UBS. He set a price target of $12.90, which indicates a 84.88% upside from the current price.

? CIXXF: CI Financial got a hold rating from Phil Hardie, a 4.92 star analyst from Scotiabank. He set a price target of $17.00, which suggests a 51.35% upside from the current price. He also gave the same rating and price target to the TSE:CIX symbol of CI Financial

? TSE:CIX: CI Financial got a hold rating from Phil Hardie, a 4.92 star analyst from Scotiabank. He set a price target of $17.50, which implies a 52.04% upside from the current price. He also gave the same rating and price target to the CIXXF symbol of CI Financial.

? SFFYF: Signify NV received a buy rating from Akash Gupta, a 0.27 star analyst from J.P.Morgan.He set a price target of $35.00, which suggests a 38.84% upside from the current price.

? FQVLF: First Quantum Minerals received five hold ratings from different analysts with similar star rankings and price targets. Liam Fitzpatrick of Deutsche Bank, Chris LaFemina of Jefferies, Greg Barnes of TD Securities, Ralph M. Profiti of Eight Capital and Shane Nagle of National Bank all set a price target of $36.00, which indicates a 20% upside from the current price. Liam Fitzpatrick, Greg Barnes and Shane Nagle also gave the same rating and price target to the TSE:FM symbol of First Quantum Minerals.

? IGIFF: IGM Financial got a hold rating from Phil Hardie, a 4.92 star analyst from Scotiabank. He set a price target of $40.00, which suggests a 34.15% upside from the current price. He also gave the same rating and price target to the TSE:IGM symbol of IGM Financial.

? ETTYF: Essity AB was rated as a buy by Charles Eden, a 1.95 star analyst from UBS. He set a price target of $285.00, which implies a 12.18% upside from the current price.

? OMC: Omnicom Group received a hold rating from Steven Cahall, a 2.73 star analyst from Wells Fargo. He set a price target of $85.00, which indicates a 22.6% upside from the current price.

? FTS: Fortis got a buy rating from Linda Ezergailis, a 4.27 star analyst from TD Securities. She set a price target of $61.00, which suggests a 3.41% upside from the current price. She also gave the same rating and price target to the TSE:FTS symbol of Fortis.

? BAYZF: Bayer got a hold rating from Richard Vosser, a 4.35 star analyst from J.P.Morgan.He set a price target of $47.00, which suggests a 56.28% upside from the current price.

? DCPH: Deciphera Pharmaceuticals received a buy rating from Tyler Van Buren, a 1.13 star analyst from TD Cowen. He set a price target of $30.00, which indicates a huge upside potential of 113.5%.

? CYJBF: Cargotec was rated as a hold by Timo Heinonen, a 5 star analyst from Handelsbanken Capital. He set a price target of $45.00, which implies a 24.44% upside from the current price.

? MPZAF: MIPS AB got a hold rating from Karri Rinta, a 1.99 star analyst from Handelsbanken Capital. He set a low price target of $360.00, which indicates a 18.98% downside from the current price.

? DAWN: Day One Biopharmaceuticals received a buy rating from Andres Y. Maldonado, a 0.33 star analyst from H.C.Wainwright.He set a high price target of $50.00, which suggests a huge upside of 276.89%.

? ELRXF: Electrolux AB was rated as a buy by Karri Rinta, a 1.99 star analyst from Handelsbanken Capital. He set a price target of $130.00, which implies an 18% upside from the current price.

? SKFRY: SKF AB received a buy rating from Hampus Engellau, a 5 star analyst from Handelsbanken Capital. He set a price target of $252.00, which suggests a 7.22% upside from the current price.

? STLA: Stellantis got a buy rating from Tim Rokossa, a 3.61 star analyst from Deutsche Bank. He set a price target of $38.00, which implies a 35.7% upside from the current price.

? AMTX: Aemetis was rated as a buy by Amit Dayal, a 4.77 star analyst from H.C.Wainwright.He set a price target of $28.00, which indicates a huge upside of 205.57%.

? DCPH: Deciphera Pharmaceuticals received two buy ratings from Tyler Van Buren of TD Cowen and Christopher Raymond of Piper Sandler, both with low star rankings. They set price targets of $30.00 and $23.00 respectively, which suggest huge upside potentials of over 110%.

? APTO: Aptose Biosciences got two buy ratings from Joseph Pantginis of H.C.Wainwright, both with very low star rankings. He set price targets of $23.00 for both the APTO and TSE:APS symbols of Aptose Biosciences, which imply massive upside potentials of over 400%.

? MCD: McDonald's received two ratings: one buy and one hold. The buy rating came from Zachary Fadem, a 4.89 star analyst from Wells Fargo, who set a price target of $310.00, which suggests a 21.03% upside from the current price. The hold rating came from Danilo Gargiulo, a 1.34 star analyst from Bernstein, who set the same price target of $300.00.

CJREF: Corus Entertainment received a buy rating from Vince Valentini, a 2.01 star analyst from TD Securities. He set a price target of $4.50, which suggests a 146% upside from the current price. He also gave the same rating and price target to the TSE:CJR.B symbol of Corus Entertainment.

? CTVA: Corteva got a buy rating from Joel Jackson, a 4.5 star analyst from BMO Capital. He set a price target of $64.00, which implies a 34.88% upside from the current price.

? MHK: Mohawk was rated as a buy by Keith Hughes, a 4.93 star analyst from Truist Financial. He set a price target of $98.00, which indicates a 25.82% upside from the current price.

Previous update:

Vinda International Holdings (VDAHF), analyzed by Linda Huang at Macquarie, is rated as BUY. It holds a 0.7-star rating with a target price of $25.30, suggesting a potential upside of 21.29%.

Li Ning Company (LNNGF), reviewed by Terence Chang at Macquarie, is designated as BUY. It maintains a 2.28-star rating with a target price of $42.00, revealing a substantial potential upside of 82.03%.

Enphase Energy (ENPH), assessed by Jordan Levy at Truist Financial, is rated as HOLD. It carries a low 0.12-star rating with a target price of $85.00, indicating a potential upside of 25.07%.

Honeywell International (HON), examined by Gautam Khanna at TD Cowen, is rated as BUY. It possesses a strong 4.93-star rating with a target price of $205.00, showing a potential upside of 25.18%.

Heidrick & Struggles (HSII), reviewed by Kevin Steinke at Barrington, is rated as BUY. It has a 4.85-star rating with a target price of $40.00, indicating a potential upside of 35.41%.

Brambles Limited (BMBLF), assessed by Justin Barratt at CLSA, is rated as BUY. It maintains a modest 1.27-star rating with a target price of $16.00, revealing a potential upside of 19.93%.

Regis Resources Limited (RGRNF), scrutinized by Kate McCutcheon at Citi, is categorized as SELL. It carries a 3.72-star rating with a target price of $1.20, indicating a potential upside of 21.3%.

Guangzhou Automobile Group Co (GNZUF), examined by Jeff Chung at Citi, is rated as BUY. It has a 0.3-star rating with a target price of $4.75, suggesting a substantial potential upside of 43.48%.

Fortescue Metals Group Ltd (FSUMF), evaluated by Paul McTaggart at Citi, is rated as SELL. It maintains a strong 4.78-star rating with a target price of $18.90, showing a potential downside of -10.62%.

Livzon Pharmaceutical Group (LVZPF), reviewed by Cui Cui at Citi, is rated as BUY. It holds a 1.65-star rating with a target price of $35.20, indicating a potential upside of 61.29%.

Arbor Realty (ABR), assessed by Steven Delaney at JMP Securities, is rated as BUY. It carries a 4.04-star rating with a target price of $19.00, revealing a potential upside of 28.02%.

Chart Industries (GTLS), scrutinized by Benjamin Nolan at Stifel Nicolaus, is rated as BUY. It has a high 4.92-star rating with a target price of $224.00, showing a substantial potential upside of 39.86%.

Spirit Airlines (SAVE), evaluated by Helane Becker at TD Cowen, is categorized as HOLD. It maintains a strong 4.95-star rating with a target price of $11.00, indicating a potential upside of 6.81%.

Boston Beer (SAM), examined by Vivien Azer at TD Cowen, is categorized as HOLD. It holds a 4.73-star rating with a target price of $350.00, revealing a potential downside of -5.34%.

SkyWest (SKYW), analyzed by Helane Becker at TD Cowen, is categorized as HOLD. It carries a strong 4.95-star rating with a target price of $50.00, showing a potential upside of 30.05%.

Dana Holding (DAN), scrutinized by Garrett Nelson at CFRA, is rated as HOLD. It has a 1.83-star rating with a target price of $14.00, indicating a potential upside of 36.74%.

Cincinnati Financial (CINF), evaluated by Catherine Seifert at CFRA, is rated as BUY. It maintains a 4.03-star rating with a target price of $115.00, revealing a potential upside of 16.87%.

Prime Medicine, Inc. (PRME), reviewed by Justin Walsh at JonesTrading, is rated as BUY. It possesses a low 0.08-star rating with a target price of $20.00, suggesting a substantial potential upside of 242.81%.

Columbia Sportswear (COLM), examined by Zachary Warring at CFRA, is designated as BUY. It carries a modest 1.57-star rating with a target price of $88.00, indicating a potential upside of 12.58%.

Nordea Bank Abp (NBNKF), assessed by Namita Samtani at Barclays, is rated as BUY. It has a 0.81-star rating with a target price of $13.60, suggesting a substantial potential upside of 386.81%.

Stanley Black & Decker (SWK), scrutinized by Eric Lau at Citi, is rated as BUY. It maintains a 3.17-star rating with a target price of $97.11, showing a potential upside of 25.74%.

Novavax (NVAX), evaluated by Mayank Mamtani at B.Riley Financial, is rated as BUY. It carries a low 0.06-star rating with a target price of $15.00, indicating a potential upside of 185.51%.

Gaming and Leisure (GLPI), examined by Carlo Santarelli at Deutsche Bank, is categorized as HOLD. It has a strong 4.97-star rating with a target price of $48.00, revealing a potential upside of 18.96%.

Crispr Therapeutics AG (CRSP), scrutinized by Salim Syed at Mizuho Securities, is designated as BUY. It maintains a low 0.11-star rating with a target price of $82.00, showing a substantial potential upside of 115.14%.

Comcast, assessed by Tim Nollen at Macquarie, is categorized as HOLD. It carries a 2.02-star rating with a target price of $43.00, indicating a potential upside of 26.36%.

Centene (CNC), analyzed by Gary Taylor at TD Cowen, is rated as BUY. It holds a 3.29-star rating with a target price of $84.00, suggesting a potential upside of 22.42%.

Universal Health (UHS), reviewed by Gary Taylor at TD Cowen, is designated as HOLD. It carries a 3.29-star rating with a target price of $140.00, revealing a potential upside of 21.45%.

Zebra Tech (ZBRA), evaluated by Meta Marshall at Morgan Stanley, is rated as SELL. It maintains a 3.68-star rating with a target price of $210.00, indicating a potential downside of 43.88%.

NerdWallet, Inc. Class A (NRDS), assessed by James Faucette at Morgan Stanley, is categorized as HOLD. It has a strong 4.66-star rating with a target price of $10.00, revealing a potential upside of 123.34%.

NY Community (NYCB), scrutinized by Manan Gosalia at Morgan Stanley, is rated as HOLD. It carries a 3.87-star rating with a target price of $12.00, showing a potential upside of 42.25%.

SLM (SLM), examined by Jeffrey Adelson at Morgan Stanley, is rated as BUY. It has a 3.11-star rating with a target price of $16.00, indicating a potential upside of 25.38%.

PTC Therapeutics (PTCT), reviewed by Jeffrey Hung at Morgan Stanley, is categorized as HOLD. It maintains a strong 4.56-star rating with a target price of $28.00, indicating a potential upside of 35.53%.

Lumentum Holdings (LITE), assessed by Meta Marshall at Morgan Stanley, is designated as HOLD. It carries a 3.68-star rating with a target price of $45.00, revealing a potential upside of 39.12%.

SS&C Technologies Holdings (SSNC), evaluated by James Faucette at Morgan Stanley, is rated as HOLD. It maintains a strong 4.66-star rating with a target price of $53.00, showing a potential upside of 36.39%.

Seagate Tech (STX), scrutinized by Erik Woodring at Morgan Stanley, is rated as HOLD. It has a low 0.43-star rating with a target price of $67.00, indicating a potential upside of 6.82%.

Principal Financial (PFG), examined by Nigel Dally at Morgan Stanley, is rated as SELL. It carries a strong 4.73-star rating with a target price of $71.00, showing a potential downside of 10.83%.

Teradyne (TER), assessed by Joseph Moore at Morgan Stanley, is rated as HOLD. It has a strong 4.7-star rating with a target price of $88.00, revealing a potential upside of 27.09%.

Merck & Company (MRK), scrutinized by Terence Flynn at Morgan Stanley, is rated as HOLD. It maintains a strong 4.75-star rating with a target price of $118.00, showing a potential upside of 18.79%.

Tractor Supply (TSCO), evaluated by Simeon Gutman at Morgan Stanley, is rated as HOLD. It carries a 2.73-star rating with a target price of $195.00, indicating a potential upside of 15.12%.

Willis Towers Watson (WTW), reviewed by Bob Huang at Morgan Stanley, is designated as HOLD. It has a 3.32-star rating with a target price of $236.00, showing a potential upside of 6.08%.

Marketaxess Holdings (MKTX), assessed by Michael Cyprys at Morgan Stanley, is categorized as HOLD. It maintains a strong 4.17-star rating with a target price of $284.00, revealing a potential upside of 17.22%.

New Gold (NGD), scrutinized by Steven Green at TD Securities, is rated as SELL. It has a low 0.69-star rating with a target price of $1.05, indicating a potential upside of 25.0%.

Juniper Networks (JNPR), evaluated by Meta Marshall at Morgan Stanley, is designated as SELL. It carries a 3.68-star rating with a target price of $27.00, revealing a potential upside of 26.52%.

Evertec (EVTC), assessed by James Faucette at Morgan Stanley, is rated as SELL. It holds a strong 4.66-star rating with a target price of $32.00, indicating a potential upside of 14.36%.

Bread Financial Holdings (BFH), scrutinized by Betsy Graseck at Morgan Stanley, is categorized as HOLD. It maintains a strong 4.17-star rating with a target price of $32.00, showing a potential upside of 48.91%.

General Motors (GM), evaluated by Adam Jonas at Morgan Stanley, is rated as BUY. It carries a 4.55-star rating with a target price of $40.00, revealing a substantial potential upside of 66.69%.

Bristol-Myers Squibb (BMY), reviewed by Matthew Harrison at Morgan Stanley, is designated as SELL. It maintains a strong 4.62-star rating with a target price of $50.00, indicating a potential upside of 20.35%.

Advance Auto Parts (AAP), assessed by Simeon Gutman at Morgan Stanley, is rated as HOLD. It has a 2.73-star rating with a target price of $55.00, showing a potential upside of 31.45%.

Blueprint Medicines (BPMC), scrutinized by Michael Ulz at Morgan Stanley, is categorized as HOLD. It maintains a low 1.12-star rating with a target price of $63.00, indicating a potential upside of 47.66%.

Brunswick (BC), analyzed by Megan Alexander at Morgan Stanley, is rated as HOLD. It holds a low 0.59-star rating with a target price of $77.00, suggesting a potential upside of 31.92%.

Hartford Financial (HIG), reviewed by Bob Huang at Morgan Stanley, is designated as HOLD. It carries a 3.32-star rating with a target price of $78.00, revealing a potential upside of 16.55%.

Hasbro (HAS), evaluated by Megan Alexander at Morgan Stanley, is rated as BUY. It maintains a low 0.59-star rating with a target price of $78.00, indicating a substantial potential upside of 33.0%.

Dexcom (DXCM), assessed by Patrick Wood at Morgan Stanley, is categorized as HOLD. It has a 1.02-star rating with a target price of $101.00, showing a potential upside of 56.14%.

Boston Beer (SAM), scrutinized by Eric Serotta at Morgan Stanley, is rated as SELL. It has a low 0.53-star rating with a target price of $285.00, indicating a potential downside of -5.34%.

Freeline Therapeutics Holdings (FRLN), reviewed by Patrick Trucchio at H.C. Wainwright, is rated as BUY. It holds a very low 0.07-star rating with a target price of $15.00, revealing a potential upside of 55.34%.

Canadian Utilities A (CDUAF), assessed by Linda Ezergailis at TD Securities, is rated as BUY. It carries a strong 4.27-star rating with a target price of $35.00, showing a potential upside of 18.39%.

Newmont Mining (NEM), examined by Brian MacArthur at Raymond James, is rated as BUY. It maintains a strong 4.52-star rating with a target price of $57.00, indicating a substantial potential upside of 33.3%.

Advantage Energy (AAVVF), scrutinized by Aaron Bilkoski at TD Securities, is rated as BUY. It has a strong 4.79-star rating with a target price of $12.00, showing a potential upside of 37.25%.

OceanaGold (OCANF), evaluated by Cosmos Chiu at CIBC, is rated as BUY. It carries a strong 4.71-star rating with a target price of $4.50, revealing a potential upside of 52.78%.

Tamarack Valley Energy (TNEYF), assessed by David Popowich at CIBC, is rated as BUY. It maintains a strong 4.45-star rating with a target price of $5.75, indicating a potential upside of 39.37%.

Allied Properties Real Estate Investment Trust (APYRF), scrutinized by Dean Wilkinson at CIBC, has a 4.76-star rating and is designated as HOLD with a target price of $19.50, suggesting a potential upside of 37.46%.

Allied Properties Real Estate Investment Trust (AP.UN), reviewed by Pammi Bir at RBC Capital, is rated as BUY. It carries a 3.99-star rating with a target price of $21.00, revealing a potential upside of 36.99%.

Canadian Utilities A (CDUAF), assessed by Mark Jarvi at CIBC, is rated as HOLD. It maintains a strong 4.62-star rating with a target price of $35.00, showing a potential upside of 18.39%.

Kenvue, Inc. (KVUE), examined by Peter Grom at UBS, is rated as HOLD. It holds a low 0.37-star rating with a target price of $20.00, suggesting a potential upside of 33.76%.

Keurig Dr Pepper (KDP), scrutinized by Peter Grom at UBS, is rated as BUY. It maintains a low 0.37-star rating with a target price of $37.00, indicating a potential upside of 20.03%.

Chemours Company (CC), assessed by Joshua Spector at UBS, is rated as BUY. It carries a 3.86-star rating with a target price of $37.00, showing a potential upside of 53.18%.

Olin (OLN), examined by Joshua Spector at UBS, is designated as HOLD. It maintains a 3.86-star rating with a target price of $49.00, revealing a potential upside of 26.44%.

Halliburton (HAL), analyzed by Josh Silverstein at UBS, is rated as BUY. It holds a strong 4.78-star rating with a target price of $51.00, suggesting a potential upside of 25.96%.

Bristol-Myers Squibb (BMY), evaluated by Trung Huynh at UBS, is designated as HOLD. It maintains a strong 4.61-star rating with a target price of $57.00, showing a potential upside of 20.35%.

H&E Equipment Services (HEES), reviewed by Steven Fisher at UBS, is rated as BUY. It carries a 3.5-star rating with a target price of $60.00, indicating a substantial potential upside of 54.14%.

Masco (MAS), scrutinized by John Lovallo at UBS, is rated as BUY. It has a 1.26-star rating with a target price of $65.00, revealing a potential upside of 22.41%.

Skechers USA (SKX), assessed by Jay Sole at UBS, is categorized as BUY. It has a strong 4.21-star rating with a target price of $66.00, showing a potential upside of 32.77%.

Boston Scientific (BSX), reviewed by Danielle Antalffy at UBS, is rated as BUY. It maintains a strong 3.78-star rating with a target price of $67.00, revealing a potential upside of 22.02%.

Columbia Sportswear (COLM), evaluated by Jay Sole at UBS, is designated as HOLD. It holds a strong 4.21-star rating with a target price of $76.00, suggesting a potential upside of 12.58%.

Paccar (PCAR), examined by Steven Fisher at UBS, is rated as HOLD. It maintains a 3.5-star rating with a target price of $90.00, showing a potential upside of 15.21%.

Teradyne (TER), assessed by Timothy Arcuri at UBS, is rated as BUY. It carries a nearly perfect 4.99-star rating with a target price of $140.00, indicating a substantial potential upside of 27.09%.

Visteon (VC), scrutinized by Joseph Spak at UBS, is rated as HOLD. It has a very low 0.28-star rating with a target price of $143.00, revealing a potential upside of 28.93%.

Dexcom (DXCM), examined by Danielle Antalffy at UBS, is rated as BUY. It has a strong 3.78-star rating with a target price of $145.00, indicating a potential upside of 56.14%.

Molina Healthcare (MOH), assessed by Kevin Caliendo at UBS, is designated as HOLD. It maintains a 3.73-star rating with a target price of $350.00, showing a potential upside of 7.43%.

Mastercard (MA), reviewed by Timothy Chiodo at UBS, is rated as BUY. It carries a 3.4-star rating with a target price of $460.00, revealing a potential upside of 23.3%.

WW Grainger (GWW), analyzed by Christopher Snyder at UBS, is rated as HOLD. It holds a 2.7-star rating with a target price of $740.00, suggesting a potential upside of 9.6%.

ON Semiconductor (ON), examined by Harsh Kumar at Piper Sandler, is rated as BUY. It carries a nearly perfect 4.97-star rating with a target price of $115.80, indicating a substantial potential upside of 39.87%.

Nvidia (NVDA), assessed by Harsh Kumar at Piper Sandler, is rated as BUY. It has a nearly perfect 4.97-star rating with a target price of $620.00, revealing a potential upside of 60.08%.

Raytheon Technologies (RTX), reviewed by Robert Czerwensky at DZ BANK AG, is designated as SELL. It has a low 1.08-star rating with a target price of $68.00, indicating a potential upside of 5.98%.

SolarWinds (SWI), scrutinized by Terry Tillman at Truist Financial, is rated as HOLD. It carries a strong 4.94-star rating with a target price of $11.00, showing a potential upside of 63.1%.

Cloudflare (NET), assessed by Brent Thill at Jefferies, is designated as HOLD. It has a very low 0.19-star rating with a target price of $60.00, revealing a potential upside of 21.56%.

Fortinet (FTNT), reviewed by Joseph Gallo at Jefferies, is rated as HOLD. It maintains a 2.7-star rating with a target price of $60.00, suggesting a potential upside of 31.01%.

Globe Life (GL), scrutinized by Catherine Seifert at CFRA, is rated as HOLD. It has a 4.03-star rating with a target price of $125.00, showing a potential upside of 15.21%.

Check Point (CHKP), examined by Joseph Gallo at Jefferies, is rated as BUY. It carries a 2.7-star rating with a target price of $160.00, indicating a potential upside of 6.3%.

Eagle Materials (EXP), evaluated by Anthony Pettinari at Citi, is rated as BUY. It has a strong 4.9-star rating with a target price of $181.00, revealing a potential upside of 36.23%.

Sangamo Biosciences (SGMO), reviewed by Patrick Trucchio at H.C. Wainwright, is rated as BUY. It carries a very low 0.07-star rating with a target price of $5.00, showing an extraordinary potential upside of 1,255.32%.

Renasant (RNST), scrutinized by Brandon King at Truist Financial, is designated as HOLD. It has a low 0.23-star rating with a target price of $26.00, indicating a potential upside of 20.54%.

Previous update:

TechnipFMC (FTI), assessed by Marc Bianchi at TD Cowen, is designated as BUY. It holds a 0.28-star rating with a target price of $25.00, indicating a potential upside of 23.23%.

Comcast (CMCSA), reviewed by Jeffrey Wlodarczak at Pivotal Research, is rated as BUY. It has a 3.68-star rating and a target price of $55.00, revealing a potential upside of 17.22%.

AT&T (T), analyzed by Ivan Feinseth at Tigress Financial, is categorized as BUY. It holds a 4.74-star rating with a target price of $28.00, suggesting a potential upside of 27.65%.

Altria Group (MO), scrutinized by Vivien Azer at TD Cowen, is rated as HOLD. It carries a 4.73-star rating and a target price of $42.00, showing a slight upside of 3.62%.

Boston Scientific (BSX), evaluated by Marie Thibault at BTIG, is given a BUY rating. It holds a 0.37-star rating with a target price of $64.00, indicating a potential upside of 22.28%.

Landstar System (LSTR), assessed by Jason Seidl at TD Cowen, is designated as HOLD. It has a high 5-star rating and a target price of $185.00, revealing a potential upside of 11.53%.

Pagaya Technologies Ltd (PGY), evaluated by David Scharf at JMP Securities, is categorized as BUY. It is rated at 4.64 stars with a target price of $2.25, indicating a significant potential upside of 207.38%.

Ladder Capital (LADR), analyzed by Steven Delaney at JMP Securities, is rated as BUY. It holds a 4.04-star rating with a target price of $12.00, suggesting a potential upside of 30.49%.

Viridian Therapeutics (VRDN), reviewed by Jason Butler at JMP Securities, is given a BUY rating. It has a low 0.07-star rating and a target price of $42.00, indicating a substantial potential upside of 264.61%.

Storagevault Canada (TSE:SVI), assessed by Mark Rothschild at Canaccord Genuity, is designated as BUY. It carries a 4.86-star rating with a target price of $5.50, showing a potential upside of 57.44%.

Allied Properties Real Estate Investment Trust (APYRF), scrutinized by Mark Rothschild at Canaccord Genuity, is rated as BUY. It holds a 4.86-star rating and a target price of $20.00, revealing a potential upside of 52.12%.

Allied Properties Real Estate Investment Trust (TSE:AP.UN), also reviewed by Mark Rothschild at Canaccord Genuity, is categorized as BUY. It has a 4.86-star rating and a target price of $20.00, indicating a significant potential upside of 54.43%.

Visteon (VC), assessed by Jeff Osborne at TD Cowen, is rated as BUY. It has a 2.33-star rating with a target price of $177.00, suggesting a potential upside of 30.86%.

Valley National Bancorp (VLY), evaluated by David Chiaverini at Wedbush, is designated as HOLD. It holds a 0.23-star rating with a target price of $9.00, showing a potential upside of 32.26%.

First Citizens BancShares (FCNCA), reviewed by David Chiaverini at Wedbush, holds a BUY rating. It is rated at 0.23 stars with a target price of $1,800.00, indicating a substantial potential upside of 33.48%.

Veritone (VERI), analyzed by Darren Aftahi at Roth MKM, is rated as SELL. It has a 4.03-star rating with a target price of $2.00, suggesting a potential upside of 9.17%.

VICI Properties (VICI), assessed by Carlo Santarelli at Deutsche Bank, is categorized as HOLD. It carries a 4.97-star rating with a target price of $32.00, revealing a potential upside of 28.63%.

NY Community (NYCB), scrutinized by David Chiaverini at Wedbush, is designated as BUY. It holds a 0.23-star rating and a target price of $12.00, indicating a potential upside of 39.8%.

Boston Scientific (BSX), evaluated by Josh Jennings at TD Cowen, is given a BUY rating. It is rated at 2.91 stars with a target price of $58.00, revealing a potential upside of 22.28%.

NovoCure (NVCR), assessed by Emily Bodnar at H.C. Wainwright, is rated as HOLD. It holds a 0.15-star rating with a target price of $25.00, indicating a significant potential upside of 181.25%.

Owens Corning (OC), reviewed by Keith Hughes at Truist Financial, is designated as HOLD. It has a 4.93-star rating and a target price of $115.00, suggesting a potential upside of 34.86%.

SLM (SLM), analyzed by David Chiaverini at Wedbush, is categorized as BUY. It has a 0.23-star rating with a target price of $16.00, indicating a potential upside of 27.87%.

Heidrick & Struggles (HSII), assessed by Tobey Sommer at Truist Financial, is rated as HOLD. It holds a 4.82-star rating with a target price of $27.00, revealing a potential upside of 45.4%.

Fortune Brands Innovations (FBIN), scrutinized by Keith Hughes at Truist Financial, holds a BUY rating. It is rated at 4.93 stars with a target price of $65.00, indicating a potential upside of 28.72%.

Amphenol (APH), evaluated by William Stein at Truist Financial, is categorized as BUY. It carries a 4.96-star rating with a target price of $97.00, showing a potential upside of 20.3%.

Masco (MAS), evaluated by Sam Reid at Wells Fargo, is given a BUY rating. It carries a 0.78-star rating with a target price of $58.00, indicating a potential upside of 33.37%.

Tractor Supply (TSCO), analyzed by Zachary Fadem at Wells Fargo, is categorized as BUY. It holds a strong 4.89-star rating and a target price of $205.00, revealing a potential upside of 12.84%.

fuboTV (FUBO), assessed by Darren Aftahi at Roth MKM, is rated as HOLD. It has a 4.03-star rating with a target price of $3.00, suggesting a potential upside of 66.67%.

Tenaya Therapeutics (TNYA), reviewed by Cory Jubinville, PhD, at LifeSci Capital, is designated as BUY. It holds a 3.58-star rating with a target price of $16.00, indicating an extraordinary potential upside of 982.47%.

UMB Financial (UMBF), scrutinized by David Long at Raymond James, is rated as BUY. It has a 3.04-star rating with a target price of $80.00, revealing a potential upside of 17.85%.

CME Group (CME), analyzed by Andrew Bond at Rosenblatt Securities, is categorized as SELL. It carries a 3.65-star rating with a target price of $180.00, showing a modest potential upside of 5.69%.

Marketaxess Holdings (MKTX), assessed by Andrew Bond at Rosenblatt Securities, is also rated as SELL. It has a 3.65-star rating with a target price of $203.00, suggesting a potential upside of 14.6%.

Biogen (BIIB), evaluated by Laura Chico at Wedbush, is designated as HOLD. It holds a 0.38-star rating with a target price of $266.00, showing a potential upside of 30.0%.

Microsoft (MSFT), reviewed by Blair Abernethy at Rosenblatt Securities, is rated as BUY. It is rated at 3.73 stars with a target price of $375.00, indicating a potential upside of 19.07%.

Phunware (PHUN), scrutinized by Darren Aftahi at Roth MKM, is categorized as BUY. It holds a high 4.03-star rating with a target price of $0.50, revealing an impressive potential upside of 929.41%.

Shenandoah Telecommunications Co (SHEN), assessed by Hamed Khorsand at BWS Financial, is designated as HOLD. It has a 4.22-star rating with a target price of $20.00, indicating a modest downside of -10.9%.

MAG Silver (MAG), reviewed by Heiko Ihle at H.C. Wainwright, is rated as BUY. It carries a low 0.07-star rating with a target price of $19.50, showing a significant potential upside of 60.06%.

Tenaya Therapeutics (TNYA), analyzed by Joseph Pantginis at H.C. Wainwright, is also designated as BUY. It has a 0.08-star rating with a target price of $18.00, indicating an extraordinary potential upside of 982.47%.

Kimco Realty (KIM), evaluated by Juan C. Sanabria at BMO Capital, is categorized as HOLD. It holds a 0.73-star rating with a target price of $19.00, revealing a potential upside of 33.82%.

Vertiv Holdings (VRT), reviewed by Brett Linzey at Mizuho Securities, is rated as HOLD. It has a 3.66-star rating with a target price of $39.00, suggesting a potential upside of 19.98%.

Fortive (FTV), assessed by Richard Eastman at Robert W. Baird, is designated as BUY. It carries an impressive 4.91-star rating with a target price of $81.00, indicating a potential upside of 23.39%.

Edwards Lifesciences (EW), scrutinized by David Rescott at Robert W. Baird, is rated as BUY. It holds a 0.87-star rating with a target price of $75.00, revealing a potential upside of 21.31%.

MSC Industrial (MSM), evaluated by David Manthey at Robert W. Baird, is given a BUY rating. It has a 4.9-star rating with a target price of $112.00, suggesting a potential upside of 19.18%.

MYR Group (MYRG), assessed by Andrew Wittmann at Robert W. Baird, is designated as BUY. It carries a 4.9-star rating with a target price of $153.00, showing a potential upside of 24.17%.

Waste Management (WM), reviewed by David Manthey at Robert W. Baird, is rated as HOLD. It holds a 4.9-star rating with a target price of $175.00, indicating a potential upside of 9.81%.

General Dynamics (GD), assessed by Peter Arment at Robert W. Baird, is given a BUY rating. It possesses a strong 4.79-star rating with a target price of $302.00, indicating a potential upside of 9.74%.

Moody's (MCO), evaluated by Jeffrey Meuler at Robert W. Baird, is categorized as BUY. It carries a 3.24-star rating and a target price of $375.00, revealing a potential upside of 16.01%.

Roper Technologies (ROP), scrutinized by Brett Linzey at Mizuho Securities, is rated as HOLD. It has a 3.66-star rating with a target price of $485.00, indicating a potential upside of 12.34%.

Roper Technologies (ROP), assessed by Richard Eastman at Robert W. Baird, is also rated as HOLD. It holds an impressive 4.91-star rating with a target price of $521.00, showing a potential upside of 12.34%.

Thermo Fisher (TMO), reviewed by Catherine Ramsey Schulte at Robert W. Baird, is designated as BUY. It carries a solid 4.47-star rating with a target price of $524.00, revealing a potential upside of 28.68%.

ServiceNow (NOW), analyzed by Robert Oliver at Robert W. Baird, is rated as BUY. It has a 4.61-star rating with a target price of $680.00, suggesting a potential upside of 23.12%.

Niu Technologies (NIU), assessed by Beatrice Lam at Citi, is categorized as HOLD. It possesses a modest 0.96-star rating with a target price of $2.30, indicating a reasonable potential upside of 11.11%.

Allison Transmission Holdings (ALSN), evaluated by Luke Junk at Robert W. Baird, is also rated as HOLD. It has a 1.14-star rating with a target price of $63.00, suggesting a modest potential upside of 4.9%.

Amphenol (APH), analyzed by Luke Junk at Robert W. Baird, is designated as BUY. It carries a 1.14-star rating with a target price of $94.00, revealing a potential upside of 20.3%.

Quest Diagnostics (DGX), reviewed by Eric Coldwell at Robert W. Baird, is rated as HOLD. It possesses a 4.25-star rating with a target price of $140.00, indicating a potential upside of 13.57%.

Avery Dennison (AVY), scrutinized by Ghansham Panjabi at Robert W. Baird, is rated as BUY. It carries a strong 4.49-star rating with a target price of $190.00, showing a potential upside of 23.2%.

Albemarle (ALB), assessed by Ben Kallo at Robert W. Baird, is designated as BUY. It has a 2.98-star rating with a target price of $210.00, indicating an impressive potential upside of 75.55%.

Align Tech (ALGN), reviewed by Jeff Johnson at Robert W. Baird, is rated as BUY. It holds a 4.76-star rating with a target price of $260.00, revealing a potential upside of 25.83%.

Dynavax (DVAX), evaluated by Edward White at H.C. Wainwright, is given a BUY rating. It possesses a 0.07-star rating with a target price of $27.00, indicating a substantial potential upside of 86.51%.

Agnico Eagle (AEM), analyzed by Greg Barnes at TD Securities, is categorized as BUY. It has a 4.16-star rating with a target price of $61.00, revealing a potential upside of 23.99%.

Papa John's International (PZZA), assessed by Nick Setyan at Wedbush, is designated as HOLD. It carries a solid 4.46-star rating with a target price of $95.00, showing a potential upside of 36.64%.

Live Nation Entertainment (LYV), reviewed by Curry Baker at Guggenheim, is rated as BUY. It holds a 4.28-star rating with a target price of $125.00, indicating an impressive potential upside of 44.86%.

Hess (HES), scrutinized by Biju Perincheril at Susquehanna, is rated as HOLD. It possesses a 4.85-star rating with a target price of $160.00, indicating a potential upside of 13.49%.

Rocket Lab USA (RKLB), assessed by Andres Sheppard at Cantor Fitzgerald, is given a BUY rating. It has a low 0.1-star rating with a target price of $6.00, showing a substantial potential upside of 105.13%.

NEXTracker, Inc. Class A (NXT), analyzed by Derek Soderberg at Cantor Fitzgerald, is categorized as BUY. It carries a high 0.98-star rating with a target price of $52.00, revealing a potential upside of 32.57%.

United Micro (UMC), reviewed by Bruce Lu at Goldman Sachs, is rated as BUY. It holds a solid 4.4-star rating with a target price of $10.20, indicating a substantial potential upside of 42.86%.

BioCryst (BCRX), assessed by Jonathan Wolleben at JMP Securities, is given a BUY rating. It possesses a low 0.15-star rating with a target price of $17.00, indicating a substantial potential upside of 218.1%.

Fortune Brands Innovations (FBIN), scrutinized by Susan Maklari at Goldman Sachs, is rated as BUY. It carries a 2.28-star rating with a target price of $68.00, revealing a potential upside of 28.72%.

Perfect Corp (PERF), analyzed by Timothy Zhao at Goldman Sachs, is designated as HOLD. It has a 1.82-star rating with a target price of $4.50, suggesting a reasonable potential upside of 60.71%.

Life Time Group Holdings (LTH), examined by Kate McShane at Goldman Sachs, is rated as HOLD. It maintains a strong 4.4-star rating with a target price of $16.00, indicating a potential upside of 82.67%.

Lithia Motors (LAD), assessed by Kate McShane at Goldman Sachs, is categorized as HOLD. It carries a 4.4-star rating with a target price of $300.00, revealing a potential upside of 43.41%.

Mattel (MAT), reviewed by Jason Haas CFA at Bank of America Securities, is given a BUY rating. It possesses a solid 4.69-star rating with a target price of $23.00, indicating a potential upside of 20.79%.

Netgear (NTGR), analyzed by Hamed Khorsand at BWS Financial, is rated as BUY. It has a 4.22-star rating with a target price of $30.00, suggesting a substantial potential upside of 187.63%.

Comcast (CMCSA), evaluated by Jessica Reif Cohen at Bank of America Securities, is designated as BUY. It carries a modest 1.09-star rating with a target price of $55.00, revealing a potential upside of 17.22%.

Starbucks (SBUX), scrutinized by Sara Senatore at Bank of America Securities, is rated as BUY. It has a 4.23-star rating with a target price of $121.00, indicating a potential upside of 16.96%.

Visteon (VC), assessed by John Babcock at Bank of America Securities, is rated as BUY. It maintains a solid 4.39-star rating with a target price of $180.00, showing a potential upside of 30.86%.

Lear (LEA), reviewed by John Murphy at Bank of America Securities, is designated as BUY. It holds a strong 4.6-star rating with a target price of $220.00, indicating a potential upside of 28.84%.

Laboratory (LH), analyzed by Derik De Bruin at Bank of America Securities, is rated as BUY. It possesses a 3.41-star rating with a target price of $230.00, revealing a potential upside of 22.63%.

Dollar Tree (DLTR), scrutinized by Charles Grom at Gordon Haskett Capital Corporation, is rated as BUY. It carries a 4.09-star rating with a target price of $135.00, showing a potential upside of 37.41%.

Norfolk Southern (NSC), assessed by Jonathan Chappell at Evercore ISI, is rated as BUY. It has a strong 4.91-star rating with a target price of $225.00, indicating a potential upside of 22.63%.

Grupo Aeroportuario del Sureste (ASR), evaluated by Stephen Trent at Citi, is designated as HOLD. It maintains a 4.49-star rating with a target price of $228.00, revealing a potential upside of 10.77%.

Meta Platforms (META), reviewed by Barton Crockett at Rosenblatt Securities, is rated as BUY. It possesses a 4.06-star rating with a target price of $411.00, indicating a potential upside of 27.57%.

Community Health (CYH), analyzed by Michael Wiederhorn at Oppenheimer, is given a BUY rating. It has a strong 4.97-star rating with a target price of $6.50, suggesting a substantial potential upside of 118.6%.

IMAX, assessed by James Goss at Barrington, is rated as BUY. It carries a low 0.12-star rating with a target price of $24.00, revealing a potential upside of 34.9%.

Viking Therapeutics (VKTX), scrutinized by Jay Olson at Oppenheimer, is designated as BUY. It maintains a high 4.55-star rating with a target price of $40.00, showing a substantial potential upside of 224.93%.

Crinetics Pharmaceuticals (CRNX), reviewed by Leland Gershell at Oppenheimer, is rated as BUY. It has a modest 0.51-star rating with a target price of $46.00, indicating a potential upside of 68.66%.

Tarsus Pharmaceuticals (TARS), analyzed by Francois Brisebois at Oppenheimer, is rated as BUY. It carries a low 0.09-star rating with a target price of $55.00, suggesting a substantial potential upside of 267.6%.

Harmony Biosciences Holdings (HRMY), assessed by Francois Brisebois at Oppenheimer, is rated as BUY. It maintains a low 0.09-star rating with a target price of $56.00, showing a reasonable potential upside of 106.08%.

SEI Investments Company (SEIC), scrutinized by Owen Lau at Oppenheimer, is rated as BUY. It possesses a strong 4.58-star rating with a target price of $65.00, revealing a potential upside of 14.89%.

Allison Transmission Holdings (ALSN), examined by Ian Zaffino at Oppenheimer, is rated as BUY. It carries a strong 4.1-star rating with a target price of $67.00, indicating a reasonable potential upside of 4.9%.

Forward Air (FWRD), assessed by Jack Atkins at Stephens, is categorized as BUY. It has a 4.53-star rating with a target price of $85.00, indicating a potential upside of 13.99%.

DoorDash (DASH), reviewed by Jason Helfstein at Oppenheimer, is designated as BUY. It maintains an impressive 4.88-star rating with a target price of $110.00, revealing a potential upside of 36.34%.

The Ensign Group (ENSG), scrutinized by Michael Wiederhorn at Oppenheimer, is rated as BUY. It possesses a strong 4.97-star rating with a target price of $115.00, showing a potential upside of 17.63%.

Dick's Sporting Goods (DKS), assessed by Brian Nagel at Oppenheimer, is categorized as BUY. It carries a strong 4.98-star rating with a target price of $145.00, indicating a potential upside of 21.39%.